Vivos Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vivos Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q3 2024.
  • Vivos Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 14, 2024 was 4.84M shares, a 304% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.84M +3.64M +304% Nov 14, 2024 10-Q 2024-11-14
Q2 2024 3.4M -26.5M -88.6% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 2.73M -26.9M -90.8% Mar 26, 2024 10-K/A 2024-07-30
Q3 2023 1.2M Nov 13, 2023 10-Q 2023-11-14
Q2 2023 29.9M +6.92M +30.1% Jun 8, 2023 10-Q 2023-06-08
Q1 2023 29.7M +6.67M +29% Mar 28, 2023 10-K 2023-03-30
Q4 2022 23M 0 0% Dec 20, 2022 10-Q 2022-12-20
Q2 2022 23M +200K +0.88% May 16, 2022 10-Q/A 2022-11-25
Q1 2022 23M +4.8M +26.4% Mar 31, 2022 10-K 2022-03-31
Q4 2021 23M Nov 15, 2021 10-Q 2021-11-15
Q2 2021 22.8M Aug 12, 2021 10-Q 2021-08-12
Q1 2021 18.2M Mar 18, 2021 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.